Compare Stocks: NEOG, BLCO, MMSI, and ICUI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLCO Bausch + Lomb	$17.04 +0.3%	$16.19	$13.77 ▼ $18.92	$6.06B	0.56	427,536 shs	237,064 shs
ICUI ICU Medical	$182.98 -0.1%	$156.56	$112.50 ▼ $192.85	$4.58B	0.74	345,241 shs	191,759 shs
MMSI Merit Medical Systems	$90.76 +0.3%	$75.05	$59.74 ▼ $94.75	$5.40B	0.49	1.17 million shs	729,848 shs
NEOG Neogen	$11.65 -2.0%	$9.95	$4.90 ▼ $12.85	$2.54B	1.77	2.34 million shs	1.59 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLCO Bausch + Lomb	+0.21%	+1.81%	+4.66%	+5.91%	+20.24%
ICUI ICU Medical	-0.07%	-0.86%	+15.84%	+54.13%	+60.33%
MMSI Merit Medical Systems	+0.29%	+1.93%	+24.26%	+47.91%	+5.35%
NEOG Neogen	-2.02%	+1.57%	+16.73%	+42.25%	+110.29%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLCO Bausch + Lomb	$17.04 +0.3%	$16.19	$13.77 ▼ $18.92	$6.06B	0.56	427,536 shs	237,064 shs
ICUI ICU Medical	$182.98 -0.1%	$156.56	$112.50 ▼ $192.85	$4.58B	0.74	345,241 shs	191,759 shs
MMSI Merit Medical Systems	$90.76 +0.3%	$75.05	$59.74 ▼ $94.75	$5.40B	0.49	1.17 million shs	729,848 shs
NEOG Neogen	$11.65 -2.0%	$9.95	$4.90 ▼ $12.85	$2.54B	1.77	2.34 million shs	1.59 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLCO Bausch + Lomb	+0.21%	+1.81%	+4.66%	+5.91%	+20.24%
ICUI ICU Medical	-0.07%	-0.86%	+15.84%	+54.13%	+60.33%
MMSI Merit Medical Systems	+0.29%	+1.93%	+24.26%	+47.91%	+5.35%
NEOG Neogen	-2.02%	+1.57%	+16.73%	+42.25%	+110.29%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLCO Bausch + Lomb	2.31	Hold	$18.75	10.05% Upside
ICUI ICU Medical	2.89	Moderate Buy	$192.80	5.37% Upside
MMSI Merit Medical Systems	2.67	Moderate Buy	$100.00	10.18% Upside
NEOG Neogen	2.17	Hold	$11.67	0.14% Upside

Current Analyst Ratings Breakdown

Latest NEOG, BLCO, MMSI, and ICUI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2026	MMSI Merit Medical Systems	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$92.00 ➝ $97.00
8/11/2026	MMSI Merit Medical Systems	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$105.00
8/7/2026	BLCO Bausch + Lomb	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/7/2026	NEOG Neogen	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/7/2026	ICUI ICU Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$170.00 ➝ $200.00
8/7/2026	ICUI ICU Medical	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Strong-Buy	$200.00
8/7/2026	ICUI ICU Medical	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$163.00 ➝ $195.00
8/7/2026	ICUI ICU Medical	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$165.00 ➝ $187.00
8/3/2026	MMSI Merit Medical Systems	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
8/3/2026	NEOG Neogen	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$11.00 ➝ $13.00
8/3/2026	BLCO Bausch + Lomb	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$20.00 ➝ $21.00

(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLCO Bausch + Lomb	$5.10B	1.19	$1.67 per share	10.18	$18.04 per share	0.94
ICUI ICU Medical	$2.23B	2.05	$14.57 per share	12.56	$86.10 per share	2.13
MMSI Merit Medical Systems	$1.52B	3.57	$5.90 per share	15.39	$28.13 per share	3.23
NEOG Neogen	$870.40M	2.92	$0.83 per share	14.10	$9.61 per share	1.21

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLCO Bausch + Lomb	-$360M	-$0.48	N/A	16.23	0.55	-3.21%	4.14%	1.93%	N/A
ICUI ICU Medical	$730K	$1.18	155.07	23.70	2.56	1.39%	7.91%	4.17%	N/A
MMSI Merit Medical Systems	$128.49M	$2.42	37.50	21.98	2.28	9.22%	13.75%	8.10%	10/29/2026 (Estimated)
NEOG Neogen	-$7.90M	-$0.03	N/A	36.41	4.69	-0.91%	2.78%	1.74%	10/8/2026 (Estimated)

Latest NEOG, BLCO, MMSI, and ICUI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	ICUI ICU Medical	$1.91	$2.37	+$0.46	$0.76	$533.44 million	$547.88 million
7/30/2026	Q2 2026	MMSI Merit Medical Systems	$0.9590	$1.19	+$0.2310	$0.65	$405.25 million	$418.84 million
7/30/2026	Q4 2026	NEOG Neogen	$0.0567	$0.09	+$0.0333	-$0.05	$212.35 million	$225.30 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLCO Bausch + Lomb	N/A	N/A	N/A	N/A	N/A
ICUI ICU Medical	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A
NEOG Neogen	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLCO Bausch + Lomb	0.79	1.55	1.02
ICUI ICU Medical	0.56	2.43	1.21
MMSI Merit Medical Systems	0.44	4.20	2.79
NEOG Neogen	0.38	3.82	2.91

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLCO Bausch + Lomb	11.07%
ICUI ICU Medical	96.10%
MMSI Merit Medical Systems	99.66%
NEOG Neogen	96.73%

Insider Ownership

Company	Insider Ownership
BLCO Bausch + Lomb	1.45%
ICUI ICU Medical	2.10%
MMSI Merit Medical Systems	0.70%
NEOG Neogen	0.55%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLCO Bausch + Lomb	13,000	357.17 million	351.99 million	Optionable
ICUI ICU Medical	13,000	24.99 million	24.47 million	Optionable
MMSI Merit Medical Systems	7,500	59.71 million	59.29 million	Optionable
NEOG Neogen	2,110	218.06 million	216.86 million	Optionable

NEOG, BLCO, MMSI, and ICUI Headlines

Recent News About These Companies

Bank of America Corp DE Has $43.11 Million Stake in Neogen Corporation $NEOG

August 13 at 3:28 AM | marketbeat.com

Surging Earnings Estimates Signal Upside for Neogen (NEOG) Stock

August 11, 2026 | zacks.com

PRGO vs. NEOG: Which Stock Is the Better Value Option?

August 10, 2026 | zacks.com

Sei Investments Co. Acquires 94,148 Shares of Neogen Corporation $NEOG

August 10, 2026 | marketbeat.com

Neogen announces board changes following director resignation

August 7, 2026 | tipranks.com

Arrowstreet Capital Limited Partnership Buys New Position in Neogen Corporation $NEOG

August 5, 2026 | marketbeat.com

Medical devices & supplies - diversified stocks Q2 results: Benchmarking Neogen (NASDAQ:NEOG)

August 4, 2026 | msn.com

Glenmede Trust Co. NA Reduces Position in Neogen Corporation $NEOG

August 2, 2026 | marketbeat.com

Don’t Just Treat BRD. Breed Around It

August 2, 2026 | drovers.comD

Can Neogen (NEOG) Justify Its Valuation On Earnings And Fiscal 2027 Guidance?

August 2, 2026 | uk.finance.yahoo.com

Neogen (NASDAQ:NEOG) reports strong Q2 CY2026, stock soars

August 1, 2026 | msn.com

Neogen’s Evolving Business Model Keeps Internal Controls a Key Financial Risk

August 1, 2026 | tipranks.com

Neogen (NASDAQ:NEOG) Posts Earnings Results, Beats Expectations By $0.04 EPS

July 31, 2026 | marketbeat.com

Neogen Corporation 2026 Q4 - Results - Earnings Call Presentation

July 31, 2026 | seekingalpha.com

Neogen Corporation $NEOG Position Boosted by Dimensional Fund Advisors LP

July 31, 2026 | marketbeat.com

Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results

July 31, 2026 | lasvegassun.comL

Neogen (NASDAQ:NEOG) Hits New 12-Month High After Earnings Beat

July 31, 2026 | marketbeat.com

Neogen (NEOG) Q4 2026 Earnings

July 30, 2026 | 247wallst.com

Neogen: Fiscal Q4 Earnings Snapshot

July 30, 2026 | chron.com

Neogen outlines $880M-$885M FY 2027 revenue and $180M-$182M adjusted EBITDA amid 50% R&D increase

July 30, 2026 | seekingalpha.com

Neogen Chemicals Publishes AGM Notice and FY26 Annual Report for Shareholders

July 30, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NEOG, BLCO, MMSI, and ICUI Company Descriptions

Bausch + Lomb NYSE:BLCO

$17.04 +0.06 (+0.34%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$17.04 +0.00 (+0.01%)

As of 08/14/2026 07:34 PM Eastern

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

ICU Medical NASDAQ:ICUI

$182.98 -0.13 (-0.07%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$182.79 -0.19 (-0.10%)

As of 08/14/2026 07:34 PM Eastern

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Merit Medical Systems NASDAQ:MMSI

$90.76 +0.26 (+0.29%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$90.70 -0.06 (-0.07%)

As of 08/14/2026 07:34 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Neogen NASDAQ:NEOG

$11.65 -0.24 (-2.02%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$11.62 -0.03 (-0.26%)

As of 08/14/2026 07:34 PM Eastern

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NEOG, BLCO, MMSI, and ICUI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NEOG, BLCO, MMSI, and ICUI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NEOG, BLCO, MMSI, and ICUI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NEOG, BLCO, MMSI, and ICUI Company Descriptions

Bausch + Lomb NYSE:BLCO

ICU Medical NASDAQ:ICUI

Merit Medical Systems NASDAQ:MMSI

Neogen NASDAQ:NEOG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NEOG, BLCO, MMSI, and ICUI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NEOG, BLCO, MMSI, and ICUI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NEOG, BLCO, MMSI, and ICUI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NEOG, BLCO, MMSI, and ICUI Company Descriptions

Bausch + Lomb NYSE:BLCO

ICU Medical NASDAQ:ICUI

Merit Medical Systems NASDAQ:MMSI

Neogen NASDAQ:NEOG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools